Status:
WITHDRAWN
Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or Overweight
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Inflammation
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
Purpose: The purpose of this study is to determine if disturbances in cytokines or factors of the metabolic syndrome, can predict complications in pregnancy, birth, and the perinatal period in pregna...
Detailed Description
Material and Method: This study falls in two fields: First 80 pregnant women with type 2 diabetes are followed with determination of cytokines and factors of the metabolic syndrome throughout the pr...
Eligibility Criteria
Inclusion
- BMI \> 30 kg/m2
- BMI \< 45 kg/m2
- Healthy
- Over 18 years of age
- No earlier preterm delivery (before 37)
- Singleton pregnancy
- 14 weeks +/- 1 week of gestation
Exclusion
- BMI \> 45 kg/m2
- Earlier preterm delivery (before 37)
- Not singleton pregnancy
- Medically treated diseases
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2008
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT00311064
Start Date
March 1 2006
End Date
January 1 2008
Last Update
August 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Obstetric Clinic, Juliane Marie Centret
Copenhagen, Østerbro, Denmark, 2100